4//SEC Filing
Raythatha Jigar 4
Accession 0001562180-20-003587
CIK 0001434418other
Filed
May 12, 8:00 PM ET
Accepted
May 13, 6:25 PM ET
Size
14.3 KB
Accession
0001562180-20-003587
Insider Transaction Report
Form 4
Raythatha Jigar
DirectorSee Remarks10% Owner
Transactions
- Exercise/Conversion
Common Stock
2020-05-11$5.51/sh+26$143→ 14,987 total - Sale
Common Stock
2020-05-11$50.00/sh−26$1,300→ 14,961 total - Exercise/Conversion
Common Stock
2020-05-12$5.51/sh+9,209$50,742→ 24,170 total - Sale
Common Stock
2020-05-12$50.17/sh−9,209$461,981→ 14,961 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-11−26→ 433,149 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (26 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-05-12−9,209→ 423,940 totalExercise: $5.51Exp: 2027-07-10→ Common Stock (9,209 underlying)
Footnotes (3)
- [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $50.00 to $50.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This option was granted on July 11, 2017. The shares underlying the option are scheduled to vest as to 25% of the shares underlying the option on March 20, 2018, with the remainder vesting in equal quarterly installments through March 20, 2021.
Documents
Issuer
CONSTELLATION PHARMACEUTICALS INC
CIK 0001434418
Entity typeother
Related Parties
1- filerCIK 0001745787
Filing Metadata
- Form type
- 4
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 6:25 PM ET
- Size
- 14.3 KB